Article info

Download PDFPDF

Original research
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

Authors

  1. Correspondence to Dr Karine Briot; karine.briot{at}aphp.fr
View Full Text

Citation

Briot K, Portale AA, Brandi ML, et al
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

Publication history

  • Received April 27, 2021
  • Accepted August 16, 2021
  • First published September 21, 2021.
Online issue publication 
September 21, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.